Drug Type Small molecule drug |
Synonyms Cilo Duo, 실로듀오서방정 |
Target |
Action inhibitors |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), PDE3 inhibitors(Phosphodiesterase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (27 Aug 2025), |
Regulation- |
Molecular FormulaC22H28FN3O6S |
InChIKeyBPRHUIZQVSMCRT-VEUZHWNKSA-N |
CAS Registry287714-41-4 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Atherosclerosis | South Korea | 27 Aug 2025 |





